Myricetin modulates streptozotocin-cadmium induced oxidative stress in long term experimental diabetic nephrotoxic rats

Journal of Functional Foods

Volumn 5, Issue 3, 2013, Pages 1466-1477

  Kandasamy, Neelamegam ^a   Ashokkumar, Natarajan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidants; Diabetic nephropathy; Myricetin; Oxidative stress

Indexed keywords

RATTUS;

EID: 84880511670     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.06.004     Document Type: Article

References (56)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126. Academic press, New York.
2. Carlberg I., Mannervik B. Purification and characterization of the flavoenzyme 322 glutathione reductase fromrat liver. The Journal of Biological Chemistry 1975, 250:5475-5480.
3. Cederberg J., Basu S., Eriksson U.J. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 2001, 44:766-774.
4. Chan H.M., Zhu L.F., Zhong R., Grant D., Goyer R.A., Cherian M.G. Nephrotoxicity in rats following liver transplantation from cadmium exposed rats. Toxicology and Applied Pharmacology 1993, 123:89-96.
5. Dajas F., Rivera F., Blasina F., Arredondo F., Echeverry C., Lafon L., et al. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotoxicity Research 2003, 5:425-432.
6. Desai I.D. Vitamin E analysis method for animal tissues. Methods in Enzymology 1984, 105:138-143.
7. Elgawish A., Glomb M., Friedlander M., Monnier V.M. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. The Journal of Biological Chemistry 1996, 271:12964-12971.
8. Ellman G.L. Tissue sulphydryl groups. Archives of Biochemistry and Biophysics 1959, 82:70-77.
9. El-Sharaky A.S., Newairy A.A., Badreldeen M.M., Ewada S.M., Sheweita S.A. Protective role of selenium against renal toxicity induced by cadmium in rats. Toxicology 2007, 235:185-193.
10. Fonseca V. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus. Current Medical Research and Opinion 2003, 19:635-641.
11. Fraga C.G., Leibovitz B.E., Tappel A.L. Lipid peroxidation measured as thiobarbituric acid reactive substances in tissue slices: characterization and comparison with homogenate and microsomes. Free Radical Biology & Medicine 1988, 4:155-161.
12. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circulation Research 2010, 107:1058-1070.
13. Gutteridge J.M.C., Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Annals of the New York Academy of Sciences 2000, 899:136-147.
14. Ha A.J., Liebler D.C. Vitamin E oxidation in rat liver mitochondria. Biochemistry 1995, 34:5754-5761.
15. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry 1974, 249:7130-7139.
16. Harnly J.M., Doherty R.F., Beecher G.R., Holden J.M., Haytowitz D.B., Bhagwat S., et al. Flavonoid content of U.S. fruits, vegetables, and nuts. Journal of Agricultural and Food Chemistry 2006, 54:9966-9977.
17. Haskins K., Bradley B., Powers K. Oxidative stress in type 1 diabetes. Annals of the New York Academy of Sciences 2003, 1005:43-54.
18. Huang D.W., Shen S.C. Caffeic acid and cinnamic acid ameliorate glucose metabolism via modulating glycogenesis and gluconeogenesis in insulin-resistant mouse hepatocytes. Journal of Functional Foods 2012, 4:358-366.
19. Jiang Z.Y., Hun J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low-density lipoprotein. Analytical Biochemistry 1992, 202:384-389.
20. Jin T., Frankel B.J. Cadmium-metallothionein nephrotoxicity is increased in genetically diabetic as compared with normal Chinese hamsters. Pharmacology and Toxicology 1996, 79:105-108.
21. Jin T., Nordberg G., Sehlin J., Wallin H., Sandberg S. The susceptibility to nephrotoxicity of Streptozotocin-induced diabetic rats subchronically exposed to Cadmium chloride in drinking water. Toxicology 1999, 142:69-75.
22. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry & Biophysics 1984, 21:130-132.
23. Kandasamy N., Ashokkumar N. Myricetin, a natural flavonoid, normalizes hyperglycemia in streptozotocin-cadmium-induced experimental diabetic nephrotoxic rats. Biomedicine and Preventive Nutrition 2012, 2:246-251.
24. Karthikesan K., Pari L., Menon V.P. Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin-nicotinamide generated oxidative stress induced diabetes. Journal of Functional Foods 2010, 2:134-142.
25. Klaassen R.B., Crenshaw K., Kozyraki R., Verroust P.J., Tio L., Atrian S., et al. Megalin mediates renal uptake of heavy metal metallothionein complexes. American Journal of Physiology Renal Physiology 2004, 287:F393-F403.
26. Kocyigit A., Keles H., Selek S., Guzel S., Celik H., Erel O. Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. Mutation Research 2005, 585:71-78.
27. + ATPase activity in kidney, brain and erythrocyte membrane in alloxan diabetic rats. Indian Journal of Experimental Biology 1992, 30:26-32.
28. Laughton M.J., Halliwell B., Evans P.J., Hoult J.R. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and Myricetin: Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochemical Pharmacology 1989, 38:2859-2865.
29. Levin R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 1990, 186:464-478.
30. Likidlilid A., Patchanans N., Peerapatdit T., Sriratanasathavorn C. Lipid peroxidationand antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. Journal of the Medical Association of Thailand 2010, 93:682-693.
31. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin-phenol reagent. The Journal of Biological Chemistry 1951, 193:265-275.
32. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: A review. The Journal of Biochemical and Molecular Toxicology 2003, 17:24-38.
33. Meister A. Glutathione metabolism and its selective modification. The Journal of Biological Chemistry 1988, 263:17205-17208.
34. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Critical Reviews in Biochemistry and Molecular Biology 2000, 35:35-70.
35. Morales A.I., Vicente-Sanchez C., Egido J., Arevalo M.A., Lopeznovo J.M. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food and Chemical Toxicology 2006, 44:2092-2100.
36. Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells tissues and fluids. Methods in Enzymology 1979, 62:1-11.
37. Parving H.H., Osterby R., Ritz E. Diabetic nephropathy. The kidney 2000, 1731-1773. Saunders W. B, Philadelphia. B.M. Brenner (Ed.).
38. Prabakaran D., Ashokkumar N. Antihyperglycemic effect of esculetin modulated carbohydrate metabolic enzymes activities in streptozotocin induced diabetic rats. Journal of Functional Foods 2012, 4:963-971.
39. Ramesh E., Jayakumar T., Elanchezhian R., Sakthivel M., Geraldine P., Thomas P.A. Green tea catechins, alleviate hepatic lipidemic- oxidative injury in Wistar rats fed an atherogenic diet. Chemico Biological Interactions 2009, 180:10-19.
40. Ratty A.K., Sunamoto J., Das N.P. Interaction of flawmoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochemical Pharmacology 1988, 37:989-995.
41. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 2006, 212:167-178.
42. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: Biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
43. Ruperez F.J., Garcia-Martinez D., Baena B., Maeso N., Cifuentes A., Barbas C., Herrera E. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. Journal of Pharmacy and Pharmacology 2008, 60:871-878.
44. 2- induced renal epithelial (LLC-PK1) cell injury. American Journal of Physiology 1995, 268:F30-F38.
45. Saxena A.K., Srivastava P., Kale R.K., Baquer N.Z. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochemical Pharmacology 1993, 45:539-554.
46. Siddique O., Sun Y., Lin J.C., Chien Y.W. Facilitated transdermal transport of insulin. Journal of Pharmaceutical Sciences 1987, 76:341-345.
47. Sinha A.K. Colorimetric assay of catalase. Analytical Biochemistry 1972, 47:389-394.
48. Smith G.E., Griffiths L.A. Metabolism of myricetin, myricitrin and 3,4,5-trihydroxyphenylacetic acid. Biochemical Journal 1970, 118:53-54.
49. Stark G. Functional consequences of membrane damage. The Journal of Membrane Biology 2005, 205:1-16.
50. Stevens M.J. Redox-based mechanisms in diabetes. Antioxidants & Redox Signaling 2005, 7:1483-1485.
51. Szkudelski T. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiological Research 2001, 50:537-546.
52. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin producing cells. Diabetes 1997, 46:1733-1742.
53. Trinder P. Plasma glucose was measured by standard methods. Annals of Clinical Biochemistry 1969, 6:24-27.
54. Annual data report: Atlas of end-stage renal disease in the United States 2003, US Renal Data System (USRDS), National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
55. Wu K.K., Huan Y. Streptozotocin-induced diabetic models in mice and rats. Current Protocols in Pharmacology 2008, 40:1-5.
56. Yamagishi S., Imaizumi V. Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Current Pharmaceutical Design 2005, 11:2279-2299.